MKI67 and prostate carcinoma: A study by Elham Hosseini-Beheshti et al. (2016) demonstrated that lEVs of commercial prostate cancer cell lines promoted the in vitro proliferation of LNCaP prostate cancer cells but also increased the volume and Ki67 expression in a mouse model [40].